Testosterone Treatment Lawsuit News: New Order Issued in Federal Testosterone Litigation, Bernstein Liebhard LLP Reports

Share Article

Order pertains to service of process for various testosterone lawsuits defendants involve involved in the proceeding.

Free Case Review
Our Firm is currently investigating a number of claims on behalf of men who allegedly suffered heart attacks, strokes, blood clots and other dangerous cardiovascular side effects due to their use of testosterone replacement therapies.

Hundreds of testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) that allege the use of prescription testosterone replacement drugs can increase a man’s risk for certain life-threatening cardiovascular events continue to move forward in a consolidated litigation underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to an Order dated December 18th, the Court has established protocols by which plaintiffs may request a waiver of service from a number of defendants, including AbbVie, Inc. and Abbott Laboratories (AbbVie defendants) Auxilium Pharmaceuticals, Inc. (Auxilium defendants); Eli Lilly and Company and Lilly USA, Inc. (Lilly defendants); Actavis, Inc., Actavis Pharma, Inc., Anda, Inc., Watson Laboratories, Inc. (Actavis defendants) and Endo Pharmaceuticals. The same Order also sets forth the manner in which plaintiffs may effect service of process on Pfizer Inc. and Pharmacia & Upjohn, (Pfizer defendants). (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is currently investigating a number of claims on behalf of a number of men who allegedly suffered heart attacks, strokes, blood clots and other dangerous cardiovascular side effects due to their use of testosterone replacement therapies. We are monitoring developments in the federal litigation closely, and are pleased to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by AndroGel and other low testosterone treatments.

Testosterone Litigation
Testosterone treatment lawsuits have been mounting in U.S. courts since the U.S. Food & Drug Administration (FDA) announced on January 31, 2014 that it had launched a review of the medications. Since then, a panel of FDA advisors has recommended that the drugs’ labels be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other issues commonly experienced by men as they age. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*

The multidistrict litigation underway in Illinois was established this past June. Court documents indicate that more than 270 testosterone lawsuits are currently pending in the proceeding, all of which were filed on behalf of men who suffered heart attacks, strokes, blood clots and other life-threatening cardiovascular events due to their use of low testosterone therapies. Among other things, the complaints allege that the manufacturers of these drugs concealed their potentially dangerous side effects from the public, and failed to warn doctors and patients about those risks. Plaintiffs further claim that sales of the medications were driven by misleading marketing claims that induced many healthy men to use the drugs in the absence of a true medical need.

Men who allegedly suffered heart attacks, stroke, deep vein thrombosis, pulmonary embolism or other serious cardiovascular problems due to their use of prescription testosterone therapies may be entitled to join this growing litigation. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*http://reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 17, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website